EBOS Group Limited ( ($NZ:EBO) ) has provided an update.
EBOS Group Limited has issued 1,030,520 options over fully paid ordinary shares under its equity plan, with each option carrying an exercise price of A$16.55 and expiring on 5 October 2036. The options are granted for nil consideration and can be exercised either with cash payment or on a cashless basis, subject to board approval, reinforcing the company’s use of share-based incentives.
Vesting of these options is generally tied to continued employment and performance testing for the period from 1 July 2026 to 30 June 2029, with board discretion for good leaver situations. Any shares issued on exercise will rank equally with existing ordinary shares, strengthening alignment between employees and shareholders and supporting EBOS’s long-term remuneration and retention framework.
More about EBOS Group Limited
EBOS Group Limited, listed on the NZX under the ticker EBO, operates in the healthcare and pharmaceutical distribution sector, providing a range of products and services across Australasia. The company uses equity-based incentive plans to align employee interests with shareholders, issuing options over fully paid ordinary shares as part of its long-term remuneration strategy.
EBOS focuses on sustaining its market position through structured capital management and employee participation in ownership, which supports retention of key staff. By granting share options that vest over multi-year periods, the group reinforces its commitment to long-term performance and operational stability in competitive healthcare markets.
For an in-depth examination of EBO stock, go to TipRanks’ Overview page.
